(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,2,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one

Published date: 2019-03-25 12:49:22

Name	(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,2,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one	CAS#	14935-81-0
Price	￥5000.0/50mg	Purity	98.0%
Stocking Period	Inquiry	Stock	In Stock

Detail Product Information Chemical & Physical Properties: CAS Number: 14935-81-0 Name: (5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,2,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one Molecular Formula: C19H28O Molecular Weight: 272.42500 Density: N/A Boiling Point: N/A Melting Point: N/A Flash Point: N/A

Changsha glory of Biological Technology Co., Ltd.

Chemsrc Level: Unverified
Tel: +86731-84392098
Address: High-tech zones in Changsha City Dongfanghong Road No. 586
Area: China
Contact: Liu. Mr
Contact Phone #: +86-18711085600
Email: 1652923704@qq.com
Website: http://www.rgdchem.com/
Major Market:
Annual Trade Volume:
Foreign Trade % of Sales:
Major partners:

Changsha glory of Biological Technology Co., Ltd. is located in Changsha High-tech Development Zone, is a research, production and sales of high-tech enterprises, mainly engaged in pharmaceutical raw materials (API), pharmaceutical intermediates, pharmaceutical impurity standard biochemical reagents development and production. Compound also undertake custom synthesis and project development services. The company has a complete hardware equipment and strong technical force, by the experts in the field, Dr. master's degrees mainly composed of highly qualified technical team, a superb synthesis technology and manufacturing capability. And the glory of a number of enterprises have established cooperative relations, to undertake various compounds customized services, commission processing production, first-class technology to provide customers with quality products. We always adhere to the "hard work, innovation and excellence" business philosophy, committed to providing quality services to our clients, and to become a new force the pharmaceutical industry to revitalize the national pharmaceutical responsibility. Welcome to come to consult colleagues in the industry to negotiate, and you would like to join hands in creating a better tomorrow!